One of the newest small cap biotechs that I’ve added to the Small Cap Gems portfolio is Conatus Pharmaceuticals (Nasdaq: CNAT). This company is a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease. The stock has an approximately $120 million market capitalization and goes for just over $7.50 a…
Why should companies build trust into their DNA as well as their daily business agenda? This is why! Trust Across America-Trust Around the World, via its FACTS® Framework has developed and refined a unique model that has been tracking the performance of the most trustworthy public companies since 2010. Every six months we update our results and share them publicly….
The long winter of falling uranium prices is about to give way to a Japanese spring. In an interview with The Mining Report, Cantor Fitzgerald’s Rob Chang discusses the return of the small producers as an increasingly hungry market looks to eat up all of the available uranium. Plus, Chang likes gold and enlightens us on how…
There can be little doubt that data releases rather than experience or intuition are driving the economic conversation. This is perhaps a function of the disconnection that many people feel about an economy that they no longer understand. Rather than trusting their own eyes or their own gut to form an opinion, it’s much easier…
Click on picture to enlarge When it comes to year to date or the past 90 days performance, the Shanghai Index is at the top of the list for both time frames! No doubt this index has been white hot of late! Even though the Shanghai has been screaming higher of late, the rally only…
Is the end of the super cycle in commodities in sight? It seems too soon to come out with a conclusion like that, although things were moving along swiftly over the past few days in a few markets. Oil and gold got the most attention, but many investors overlooked copper which dipped below 3 dollars….
(VIX) has been unable to make lower lows as stocks made higher highs in recent weeks as it appears managers protected these insane gains of the last few weeks rather than piled in – beta-chase-style – as financial media would have us believe. VIX has broken back above 16 this morning adding to its biggest 2-day surge…
The stock whisper of the day is: (AUY). Video Length: 00:02:27
Earlier this week Daniel Druger and Liz McCormick wrote an article for Bloomberg entitled: “One Hundred Years Of Bond History Means Bears Destined To Lose.” The crux of the article is contained within the following paragraph: “With the longest-dated Treasuries now yielding less than half the 6.8 percent average over the past five decades, it’s not hard…
Shares of Bluebird Bio (BLUE) jumped 60% on the open after it had announced that one if its drugs, Lentiglobin BB305, which utilizes gene therapy, was able to allow patients to become transfusion free. Bluebird Bio is a biotechnology stock that is developing treatments for rare genetic disorders. This result of allowing patients to become tranfusion-free is…
